To investigate whether ANLN protein was overexpressed in BLCA and could serve as biomarker for prognosis, we evaluated its expression by immunohistochemical analysis in 209 patients who underwent cystectomy or transurethral resection of BLCA. This evidence concerns the gene ANLN and bladder transitional cell carcinoma.